Public Profile

Hikma Labs Inc.

Hikma Labs Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2007, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty medications. Hikma Labs is renowned for its innovative approach to drug formulation, focusing on complex generics and injectables that address critical healthcare needs. Their commitment to quality and compliance has earned them a strong market position, with notable achievements in regulatory approvals and product launches. With a diverse portfolio of core products, Hikma Labs continues to enhance patient care through accessible and effective therapeutic solutions, solidifying its reputation as a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Hikma Labs Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Hikma Labs Inc.'s score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

46%

Let us know if this data was useful to you

Hikma Labs Inc.'s reported carbon emissions

Hikma Labs Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or commitments outlined in their initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their climate impact or commitments in detail. However, the absence of data may indicate a need for further transparency in their environmental strategies. As the industry increasingly prioritises sustainability, it is essential for companies like Hikma Labs Inc. to establish clear climate commitments and measurable targets to align with global efforts in reducing carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hikma Labs Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hikma Labs Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hikma Labs Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hospira

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Auro Medics Pharma Llc

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 27 minutes ago

Amneal

US
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Bedford Laboratories

US
Updated 4 months ago
DitchCarbon Score

Padagis US LLC

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers